Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Blood (2024) 144 (Supplement 1): 1250.

https://doi.org/10.1182/blood-2024-201997

Published: 2024

Journal Articles

The Anti-Leprosy Agent Clofazimine Inhibits FLT3-ITD Mutant AML Stem Cells and Potently Enhances Effects of TKI

Harish Kumar, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Sabyasachi Sanyal, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 11533–11534.

https://doi.org/10.1182/blood-2022-169220

Published: 2022

Journal Articles

PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Harish Kumar, Aditi Dhir, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Xinyang Zhao, Rui Lu, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 3073–3074.

https://doi.org/10.1182/blood-2022-168326

Published: 2022

Journal Articles

Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange

Jacob R. Anderson, Jing Li, Timothy A. Springer, Alan Brown

Blood (2022) 140 (12): 1419–1430.

https://doi.org/10.1182/blood.2022016467

Published: 2022

Includes: Multimedia, Supplemental data

Journal Articles

CXCL12 Knock-out Enhances Leukemia Stem Cell Response to Combination Chemotherapy Plus Tyrosine Kinase Inhibition in Flt3-ITD Acute Myeloid Leukemia

Nick R Anderson, BS, Hui Li, BS, Mason W Harris, Shaowei Qiu, MD, Amanda K Mullen, Andrew J Paterson, PhD, Ravi Bhatia, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-142579

Published: 2020

Journal Articles

D-Dimer As a Predictor of Thrombotic Events during Early Acute Lymphoblastic Leukemia Therapy

Daniela R. Anderson, MD, Avi Leader, MD, Theodore G. Karrison, PhD, Wendy Stock, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140324

Published: 2020

Journal Articles

An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors

Aditi Dhir, MD, Andrew J Paterson, PhD, Shaowei Qiu, MD, Amanda K Mullen, Nick R Anderson, BS, Ravi Bhatia, MD

Blood (2019) 134 (Supplement_1): 2524.

https://doi.org/10.1182/blood-2019-125178

Published: 2019

Journal Articles

Identifying the Leukemia Stem Cell Niche Mediating Drug Resistance in Flt3-ITD Acute Myeloid Leukemia

Nick R Anderson, BS, Hui Li, BS, Mason W Harris, Shaowei Qiu, MD, Andrew J Paterson, PhD, Ravi Bhatia, MD

Blood (2019) 134 (Supplement_1): 909.

https://doi.org/10.1182/blood-2019-124379

Published: 2019

Journal Articles

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Aleksandra Kajetanowicz, BSc, Sudeep P Shivakumar, MD BSc, Steve Doucette, MSc, Susan Pleasance, BSN, Christopher Green, MD, Allen Tran, MDBSc, David R. Anderson, MD

Blood (2019) 134 (Supplement_1): 1148.

https://doi.org/10.1182/blood-2019-129140

Published: 2019

Journal Articles

Impact of Perioperative Tranexamic Acid on Risk of Bleeding in Total Hip and Knee Arthroplasty: An Analysis of the Epcat II Data

Sudeep P Shivakumar, MD BSc, Daniel E Singer, MD MA, Steve Doucette, David R. Anderson, MD

Blood (2018) 132 (Supplement 1): 2487.

https://doi.org/10.1182/blood-2018-99-119189

Published: 2018

Journal Articles

Role of Enhanced Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment

Shaowei Qiu, MD, Andrew J Paterson, PhD, Ajay Abraham, PhD, Jianbo He, MD, Mansi Shah, PhD, Puneet Agarwal, PhD, Amanda K Mullen, Hui Li, BS, Mason W Harris, Nicholas R Anderson, Ravi Bhatia, MD

Blood (2018) 132 (Supplement 1): 1358.

https://doi.org/10.1182/blood-2018-99-115702

Published: 2018

Journal Articles

RNA-Sequencing of Isolated Cell Populations Expressing Human APOL1 Risk Variants Reveals Molecular Correlates of Sickle Cell Nephropathy in Zebrafish Podocytes

Joseph L Bundy, PhD BS, Blair R Anderson, PhD, Ludmila Francescatto, PhD, Melanie E Garrett, MS, Karen L Soldano, BS, Marilyn J. Telen, MD, Erica E Davis, PhD, Allison E Ashley-Koch, PhD

Blood (2017) 130 (Supplement 1): 2236.

https://doi.org/10.1182/blood.V130.Suppl_1.2236.2236

Published: 2017

Journal Articles

GWAS Meta-Analysis of Glomerular Filtration Rate in Three Cohorts of Sickle Cell Disease Patients and In Vivo Functional Analysis Reveals Potential Nephropathy Candidate Genes

Blair R. Anderson, BS, Melanie E. Garrett, MS, Karen L. Soldano, BS, Eugene P. Orringer, MD, James R. Eckman, MD, Ludmila Francescatto, PhD, Erica E. Davis, PhD, Mark T. Gladwin, MD, Victor R. Gordeuk, MD, Marilyn J. Telen, MD, Allison E. Ashley-Koch, PhD

Blood (2016) 128 (22): 269.

https://doi.org/10.1182/blood.V128.22.269.269

Published: 2016

Journal Articles

Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy

Melanie E. Garrett, Karen L. Soldano, Blair R. Anderson, Marilyn J. Telen, MD, Allison E. Ashley-Koch, PhD

Blood (2015) 126 (23): 3401.

https://doi.org/10.1182/blood.V126.23.3401.3401

Published: 2015

Journal Articles

Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model

Blair R. Anderson, Erica E. Davis, PhD, Marilyn J. Telen, MD, Allison E. Ashley-Koch, PhD

Blood (2014) 124 (21): 1374.

https://doi.org/10.1182/blood.V124.21.1374.1374

Published: 2014

Journal Articles

Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients

Melanie E. Garrett, MS, Karen L. Soldano, B.S., Blair R. Anderson, Eugene P. Orringer, MD, James R. Eckman, MD, Marilyn J. Telen, MD, Allison E. Ashley-Koch, PhD

Blood (2014) 124 (21): 1381.

https://doi.org/10.1182/blood.V124.21.1381.1381

Published: 2014

Journal Articles

In Vivo Modeling Of Genetic Mechanisms Associated With Sickle Cell Disease Nephropathy

Blair R Anderson, Erica E Davis, PhD, Marilyn J. Telen, MD, Allison E Ashley-Koch, PhD

Blood (2013) 122 (21): 2224.

https://doi.org/10.1182/blood.V122.21.2224.2224

Published: 2013

Journal Articles

Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling

Nermi L. Parrow, Sara Gardenghi, Pedro Ramos, Carla Casu, Robert W. Grady, Erik R. Anderson, Yatrik M. Shah, Huihui Li, Yelena Z. Ginzburg, Robert E. Fleming, Stefano Rivella

Blood (2012) 119 (13): 3187–3189.

https://doi.org/10.1182/blood-2012-01-405563

Published: 2012

Journal Articles

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Megan S. Lim, MD, PhD, Karen Pulford, PhD, FRCPath, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Marsha C. Kinney, MD, Sherrie L. Perkins, MD, PhD, James R. Anderson, PhD, Lynette Smith, MS, Mitchell S. Cairo, MD, Sheila Weitzman, MB, Thomas G. Gross, MD, PhD, Jacqueline M. Kraveka, DO

Blood (2010) 116 (21): 4130.

https://doi.org/10.1182/blood.V116.21.4130.4130

Published: 2010

Journal Articles

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial

Blood (2008) 112 (12): 4432–4436.

https://doi.org/10.1182/blood-2008-06-163279

Published: 2008

NARROW

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

The Anti-Leprosy Agent Clofazimine Inhibits FLT3-ITD Mutant AML Stem Cells and Potently Enhances Effects of TKI

PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange

CXCL12 Knock-out Enhances Leukemia Stem Cell Response to Combination Chemotherapy Plus Tyrosine Kinase Inhibition in Flt3-ITD Acute Myeloid Leukemia

D-Dimer As a Predictor of Thrombotic Events during Early Acute Lymphoblastic Leukemia Therapy

An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors

Identifying the Leukemia Stem Cell Niche Mediating Drug Resistance in Flt3-ITD Acute Myeloid Leukemia

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Impact of Perioperative Tranexamic Acid on Risk of Bleeding in Total Hip and Knee Arthroplasty: An Analysis of the Epcat II Data

Role of Enhanced Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment

RNA-Sequencing of Isolated Cell Populations Expressing Human APOL1 Risk Variants Reveals Molecular Correlates of Sickle Cell Nephropathy in Zebrafish Podocytes

GWAS Meta-Analysis of Glomerular Filtration Rate in Three Cohorts of Sickle Cell Disease Patients and In Vivo Functional Analysis Reveals Potential Nephropathy Candidate Genes

Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy

Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model

Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients

In Vivo Modeling Of Genetic Mechanisms Associated With Sickle Cell Disease Nephropathy

Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only